PCN41 COST-EFFECTIVENESS OF TAC VERSUS FAC FOR THE TREATMENT OF NODE POSITIVE BREAST CANCER IN THE ADJUVANT SETTING

M Fonseca; G Araujo; E Saad; R Uehara

doi:10.1016/s1098-3015(10)63471-7

PCN41 COST-EFFECTIVENESS OF TAC VERSUS FAC FOR THE TREATMENT OF NODE POSITIVE BREAST CANCER IN THE ADJUVANT SETTING

Value in Health ◽

10.1016/s1098-3015(10)63471-7 ◽

2006 ◽

Vol 9 (6) ◽

pp. A288

Author(s):

M Fonseca ◽

G Araujo ◽

E Saad ◽

R Uehara

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Setting ◽

Node Positive ◽

Positive Breast Cancer

Get full-text (via PubEx)

Docetaxel in Combination with Doxorubicin and Cyclophosphamide as Adjuvant Treatment for Early Node-Positive Breast Cancer in the USA: A Cost-Effectiveness and Cost-Utility Analysis.

10.1158/0008-5472.sabcs-09-2091 ◽

2009 ◽

Author(s):

S. Wolowacz ◽

B. Seal ◽

M. Tangirala

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Treatment ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Node Positive ◽

The Usa ◽

Positive Breast Cancer

Get full-text (via PubEx)

Cost–effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)

Breast Cancer Research and Treatment ◽

10.1007/s10549-008-0035-0 ◽

2008 ◽

Vol 114 (3) ◽

pp. 589-595 ◽

Cited By ~ 16

Author(s):

Sang Gyu Lee ◽

Young Geon Jee ◽

Hyun Chul Chung ◽

Sung-Bae Kim ◽

Jungsil Ro ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Therapy ◽

Cost Effectiveness Analysis ◽

Node Positive ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Get full-text (via PubEx)

Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide + methotrexate + fluorouracil in patients with node-positive breast cancer

European Journal of Clinical Pharmacology ◽

10.1007/s002280050169 ◽

1996 ◽

Vol 51 (2) ◽

pp. 111-116 ◽

Cited By ~ 22

Author(s):

A. Messori ◽

P. Becagli ◽

S. Trippoli ◽

E. Tendi

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Chemotherapy ◽

Node Positive ◽

Positive Breast Cancer

Get full-text (via PubEx)

Cost effectiveness of TAC versus FAC in adjuvant treatment of node-positive breast cancer

Current Oncology ◽

10.3747/co.v17i1.445 ◽

2010 ◽

Vol 17 (1) ◽

Author(s):

M. Koo ◽

N. Mittmann ◽

S. Verma ◽

K. Alloul ◽

M. Trudeau

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Adjuvant Treatment ◽

Node Positive ◽

Positive Breast Cancer

Get full-text (via PubEx)

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

Cancer ◽

10.1002/cncr.22806 ◽

2007 ◽

Vol 110 (3) ◽

pp. 489-498 ◽

Cited By ~ 73

Author(s):

Louis P. Garrison ◽

Deborah Lubeck ◽

Deepa Lalla ◽

Virginia Paton ◽

Amylou Dueck ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Adjuvant Setting ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Effectiveness Analysis ◽

Positive Breast Cancer

Get full-text (via PubEx)

Potential Predictive Value of Bcl-2 for Response to Tamoxifen in the Adjuvant Setting of Node-Positive Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2004.n.043 ◽

2004 ◽

Vol 5 (5) ◽

pp. 364-369 ◽

Cited By ~ 12

Author(s):

Fatima Cardoso ◽

Marianne Paesmans ◽

Denis Larsimont ◽

Virginie Durbecq ◽

Chantal Bernard-Marty ◽

...

Keyword(s):

Breast Cancer ◽

Predictive Value ◽

Adjuvant Setting ◽

Node Positive ◽

Positive Breast Cancer

Get full-text (via PubEx)

Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects

Breast Cancer Research and Treatment ◽

10.1007/s10549-008-0034-1 ◽

2008 ◽

Vol 114 (3) ◽

pp. 579-587 ◽

Cited By ~ 13

Author(s):

Heather-Jane Au ◽

Kamran Golmohammadi ◽

Tallal Younis ◽

Shailendra Verma ◽

Stephen Chia ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Node Positive ◽

Effectiveness Analysis ◽

Downstream Effects ◽

Cancer Modeling ◽

Positive Breast Cancer

Get full-text (via PubEx)

PCN8 COST-EFFECTIVENESS OF ANASTROZOLE VERSUS TAMOXIFEN FOR THE TREATMENT OF POST MENOPAUSAL HORMONE-RECEPTOR POSITIVE BREAST CANCER (BC) IN THE ADJUVANT SETTING IN BRAZIL

Value in Health ◽

10.1016/s1098-3015(10)68919-x ◽

2007 ◽

Vol 10 (3) ◽

pp. A125

Author(s):

M Fonseca ◽

G Araujo ◽

E Saad

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Hormone Receptor ◽

Adjuvant Setting ◽

Hormone Receptor Positive ◽

Post Menopausal ◽

Positive Breast Cancer

Get full-text (via PubEx)

Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study

Annals of Oncology ◽

10.1093/annonc/mdp561 ◽

2010 ◽

Vol 21 (7) ◽

pp. 1448-1454 ◽

Cited By ~ 13

Author(s):

P. Marino ◽

C. Siani ◽

H. Roché ◽

C. Protière ◽

P. Fumoleau ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Economic Study ◽

Node Positive ◽

Positive Breast Cancer

Get full-text (via PubEx)

Determination of a Unique Pattern of Gene Expression in Node Positive Breast Cancer Using Serial Analysis of Gene Expression (SAGE)

10.21236/ada417855 ◽

2002 ◽

Author(s):

Adam M. Brufsky

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Unique Pattern ◽

Node Positive ◽

Positive Breast Cancer

Get full-text (via PubEx)